These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 20099583)
21. The drive for a safer chemicals policy in the United States. Belliveau ME New Solut; 2011; 21(3):359-86. PubMed ID: 22001036 [TBL] [Abstract][Full Text] [Related]
22. Environmental pediatrics and its impact on government health policy. Goldman L; Falk H; Landrigan PJ; Balk SJ; Reigart JR; Etzel RA Pediatrics; 2004 Apr; 113(4 Suppl):1146-57. PubMed ID: 15060212 [TBL] [Abstract][Full Text] [Related]
23. What are the policy lessons of National Alcohol Prohibition in the United States, 1920-1933? Hall W Addiction; 2010 Jul; 105(7):1164-73. PubMed ID: 20331549 [TBL] [Abstract][Full Text] [Related]
24. Developing regulations for occupational exposures to health hazards in Malaysia. Rampal KG; Mohd Nizam J Regul Toxicol Pharmacol; 2006 Nov; 46(2):131-5. PubMed ID: 16899331 [TBL] [Abstract][Full Text] [Related]
25. Regulation of genetic engineering: less concern about Frankensteins but time for action on commercial production. Karny GM Univ Toledo Law Rev; 1981; 12(4):815-68. PubMed ID: 11649588 [No Abstract] [Full Text] [Related]
26. The first pharmacoepidemiologic investigations: national drug safety policy in the United States, 1901-1902. Lilienfeld DE Perspect Biol Med; 2008; 51(2):188-98. PubMed ID: 18453724 [TBL] [Abstract][Full Text] [Related]
27. Analyzing the benefits of regulation: the OSHA EtO report. Healthc Hazard Mater Manage; 1992 Dec; 6(3):5-8. PubMed ID: 10123224 [No Abstract] [Full Text] [Related]
28. FDA policy on unapproved drug products: past, present, and future. Chhabra R; Kremzner ME; Kiliany BJ Ann Pharmacother; 2005; 39(7-8):1260-4. PubMed ID: 15956239 [TBL] [Abstract][Full Text] [Related]
29. FDA audit of nonclinical studies. Horowitz AM Qual Assur; 1995 Sep; 4(3):227-38. PubMed ID: 8705117 [TBL] [Abstract][Full Text] [Related]
30. US regulatory system for genetically modified [genetically modified organism (GMO), rDNA or transgenic] crop cultivars. McHughen A; Smyth S Plant Biotechnol J; 2008 Jan; 6(1):2-12. PubMed ID: 17956539 [TBL] [Abstract][Full Text] [Related]
32. Drug regulation and policy formulation. Nightingale SL Milbank Mem Fund Q Health Soc; 1981; 59(3):412-44. PubMed ID: 7024847 [TBL] [Abstract][Full Text] [Related]
33. Biotechnology: can a new technology survive? Withers WW; Kenworthy PG St Louis Univ Law J; 1987; 31(3):673-97. PubMed ID: 11650845 [No Abstract] [Full Text] [Related]
34. Law-medicine notes. An end to federal regulation: the good, the bad, and the unnecessary. Curran WJ N Engl J Med; 1982 Mar; 306(11):653-4. PubMed ID: 6799825 [No Abstract] [Full Text] [Related]
35. Registration of food facilities under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002. Final rule. Food and Drug Administration, HHS Fed Regist; 2005 Oct; 70(190):57505-9. PubMed ID: 16200686 [TBL] [Abstract][Full Text] [Related]
36. A review of public health regulations on lead. Johnson BL; Mason RW Neurotoxicology; 1984; 5(3):1-22. PubMed ID: 6542973 [TBL] [Abstract][Full Text] [Related]
37. Business and health care policy reform in the 1980s: the 50 states. Mintz B; Palmer D Soc Probl; 2000; 47(3):327-59. PubMed ID: 17649603 [No Abstract] [Full Text] [Related]
38. In the arc of history: AIHA and the movement to reform the Toxic Substances Control Act. Wilson MP J Occup Environ Hyg; 2012; 9(5):D87-94. PubMed ID: 22530686 [TBL] [Abstract][Full Text] [Related]
39. Regulatory and other public policy issues. Hyman WA; Brannigan VM; McDermott JJ; Willingmyre GT; Estrin NF IEEE Eng Med Biol Mag; 1989; 8(3):33-40. PubMed ID: 18244084 [TBL] [Abstract][Full Text] [Related]
40. Review of the Federal Child Labor Regulations: updating hazardous and prohibited occupations. Miller ME; Bush D Am J Ind Med; 2004 Feb; 45(2):218-21. PubMed ID: 14748053 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]